Susan Hasty, Publisher
Table of Contents . . . May 26th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in FDA Law Weekly | Other Publications
AMTSystems - Identification device for surgical safety introduced in healthcare industry
Adeza - Test assesses risk of preterm birth
Adventrx Pharmaceuticals, Inc. - U.S. FDA grants clearance for CoFactor phase III trial in colorectal cancer
Alcon, Inc. - New intraocular lens launched
BioAlliance Pharma - U.S. FDA grants orphan drug designation for doxorubicin Transdrug
Cellegy Pharmaceuticals, Inc. - Pharmaceutical firm responds to U.S. FDA inquiries about Cellegesic
Centers for Medicare & Medicaid Services - CMS proposes FY 2006 rate increases for inpatient stays in acute care hospitals
Ciphergen Biosystems, Inc. - Agreement signed to evaluate proteomic system for ovarian cancer diagnostics
Cook Biotech, Inc. - FDA clears Surgisis AFP Fistula Plug for fistula repair
Cordis Corporation - FDA grants approval of MRI immediately after stent implantation
Cytopia, Ltd. - Company gets green light for CYT997 trial
Dade Behring - Company submits 510k for its Dimension Vista 1500 Analyzer
Exelixis, Inc. - Company files IND application for anticancer compound XL820
Finance - Kindred Healthcare announces first quarter financial results
GlaxoSmithKline - Agreement reached on consent decree re Cidra, Puerto Rico, manufacturing site
A.P. Pharma, Inc. - APF530 phase II trial program initiated in cancer patients
AEterna Zentaris, Inc. - Positive phase I results reported on oral growth hormone
Academy of Sciences of the Czech Republic - Vaccine generated by fusing dendritic cells and HPV-related tumor cells
Acadia Pharmaceuticals, Inc. - Pharmaceutical firm elects Mary Ann Gray to board of directors
Acusphere, Inc. - Hydrophobic drug delivery system reported in journal
Agriculture University of Warsaw - 2-Substituted halogenobenzimidazoles have antimycobacterial activity
Akdeniz University - Antioxidant vitamins prevent inflammatory effects of exhausting exercise
Albert Einstein College of Medicine - Efficacy of taxol affected by mitogen-activated protein kinase inhibitor CI-1040
Amylin Pharmaceuticals, Inc. - Exenatide improves insulin sensitivity and beta-cell mass
Anika Therapeutics, Inc. - Medical device firm reports 19% increase in first quarter revenue
Bentley Pharmaceuticals, Inc. - Approval granted to market generic versions of risperidone in Spain
Biomarker Technologies LLC - Participants sought for upcoming clinical trial of blood test
Biovac Institute - Recent findings in tuberculosis vaccines described
BrainStorm Cell Therapeutics - Neurologists appointed to scientific advisory board at stem cell company
Bristol Royal Infirmary - Preoperative clopidogrel exposure raises morbidity/mortality risk
Brown University - Studies describe new findings in tuberculosis vaccines research
CNRS, Chatenay Malabry - Drugs of the styrylquinoline class inhibit HIV-1 integrase
CNRS, Montpellier - Molecular changes associated with agonist activity of hydroxy-tamoxifen
Calando Pharmaceuticals, Inc. - Delivery technology achieves tumor knockdown with targeted siRNA
Callerio Foundation Onlus, Trieste - NAMI-A exhibited antimetastatic effects on KB tumor cells
Catholic University of Korea, Seoul - p53 may have a role in adriamycin-induced caspase-independent apoptosis
Cell Genesys, Inc. - Company launches phase I trial of CG0070 in recurrent bladder cancer
Chang Gung University, Taoyuan - Damaged DNA-binding protein 2 plays a major role in resistance to apoptosis
Chicago Medical School - Insulin gene therapy may overcome the drawbacks of islet transplantation
Chinese Academy of Science, Shanghai - SARS CoV 3CL(pro) indispensable for proteolytic activity/not enzyme dimerization
Christie Hospital NHS Trust, Manchester - Anti-VEGF antibody possesses clinical activity in advanced cancer patients
Chung Shan Medical University, Taichung - Chingwaysan induced apoptosis in human oral cancer cell lines, OC2 and TSCCa
CombinatoRx, Inc. - Biopharmaceutical firm receives $4.4M grant for anthrax research
Corgentech, Inc. - Maker of DNA-based therapeutics reports Q1 revenue of $5.5 million
CuraGen Corp. - Genomics-based pharma reports Q1 net loss of $19.4 million
Dade Behring - Company announces availability of Emit II Plus Ecstasy Assay
Danish Institute for Food & Vet. Research, Soeborg - Recent findings in cardioprotection provide new insights
Deaconess Arthritis Center, Cincinnati - Options for treatment of bone loss in postmenopausal women reviewed
Depomed, Inc. - Company to develop extended-release form of compound for Boehringer
Diet & Nutrition - U.S. FPA director comments on Institute of Medicine report
Drexel University - Treatment adherence associated with lower quality of life in children
DrugMax, Inc. - Pharmacy announces fourth-quarter and full-year 2004 results
Dynavax Technologies Corp. - Immuno-focused company reports Q1 revenue of $12.7 million
EIC Laboratories, Inc. - Star amphiphilic block copolymer developed as drug carrier
Eastern Virginia Medical School - Multi-country Phase III clinical trials to test microbicides against HIV
Emory University - Best heart-healthy diet combines parts of popular plans
Endocyte Inc. - Folate receptor expression in cancer determined by radioligand binding assay
Erasmus Medical Center - Kidney growth in diabetic mice not affected by IGF binding protein
Evotec OAI, AG - Company extends global medicinal chemistry agreement with Roche
HealthGrades - Gap widens between best and worst hospitals
Insurance Federation of Minnesota - Insurance federation warns about legal issues with dog bites
Pennsylvania Department of Health - Health department reminds public of precautions for West Nile virus
Prestwick Pharmaceuticals, Inc. - Pharma company submits NDA to U.S. FDA to market tetrabenazine
SpinalMotion, Inc. - U.S. FDA grants approval for clinical studies of lumbar, cervical disk implants
U London Royal Holloway & Bedford New Coll, Egham - T cell vaccine might work against high- but not low-dose HIV exposure
U.S. Food & Drug Administration - Diethanolamine measured in shampoo containing fatty acid diethanolamide
U.S. Food & Drug Administration - Method to determine oxytetracycline in salmon developed
U.S. Food & Drug Administration - Peptide vaccine excludes antigen-specific T cells from splenic lymph
U.S. Food & Drug Administration - Rapid method for phenotypic characterization of Salmonella developed
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.